Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check20 days agoChange DetectedA sitewide notice was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.8%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov site footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history shows the contact information label was updated in capitalization, and a new site version v3.7.0 was added while the older label and version (Find Contact Information, v3.6.6) were removed; together these illustrate a minor UI text adjustment and a software release entry on the page.SummaryDifference0.2%

- Check76 days agoChange DetectedA new revision entry v3.6.6 was added to the study's Record History, and the previous revision v3.6.5 was removed. This reflects an updated version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.